Trial · NCT00114972
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Primary Clinical Endpoint of 12-Month Binary MACCE. | 12 months post enrollment | ITT analysis. Number of participants analyzed equals number of subjects who completed Overall Study, as listed in Participant Flow. | participants | NUMBER |
| PRIMARY | 12-month Composite Safety Endpoint. | 12 months after enrollment | participants | NUMBER | |
| SECONDARY | Overall MACCE at 1 Month Post-procedure and at 6 Months, 3 Years, and 5 Years Post-allocation. | 1 month after procedure and 6 months, 3 years, and 5 years post allocation | participants | NUMBER | |
| SECONDARY | Individual Components of MACCE at 1 Month Post-procedure. | 1 month after procedure | ITT analysis | participants | NUMBER |
| SECONDARY | Individual Components of MACCE at 6 Months Post-allocation. | 6 months post allocation | ITT analysis | Participants | NUMBER |
| SECONDARY | Individual Components of MACCE at 1 Year Post-allocation. | 1 year post allocation | ITT analysis | participants | NUMBER |
| SECONDARY | Freedom From MACCE and Its Components at 1 Year Post-allocation. | 1 year post allocation | participants | NUMBER | |
| SECONDARY | Freedom From MACCE and Its Components at 3 Years Post-allocation | 3 years post allocation | participants | NUMBER | |
| PRIMARY | Repeat Revascularization (PCI and/or CABG). | 12 Months post enrollment | Participants | NUMBER | |
| SECONDARY | Freedom From MACCE and Its Components at 5 Years Post-allocation | 5 years post allocation | participants | NUMBER | |
| SECONDARY | Quality of Life at 1 Month Post-procedure and at 6 Months, 1, 3 and 5 Years Post-allocation | 1 month after procedure and 6 months, 1, 3 and 5 years post allocation | |||
| SECONDARY | Cost and Cost-effectiveness at 1, 3 and 5 Years Post-allocation | 1 year, 3 and 5 years post allocation | |||
| SECONDARY | The Characteristics (Including Co-morbidity and Coronary Vascular Lesion Complexity Scoring Referred to as the SYNTAX Score) of the Following: PCI Versus CABG Randomized Cohort, PCI Registry Cohort (CABG Ineligible), CABG Registry Cohort (PCI Ineligible) | 5 Years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00114972/outcomes